Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Huajun Qu"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThis study was designed to assess ferroptosis regulator gene (FRG) expression patterns in patients with TNBC based on data derived from The Cancer Genome Atlas (TCGA). Further, it was utilized to establish a TNBC FRG signature, after which t
Externí odkaz:
https://doaj.org/article/9103544d04d742c6a31879ae80c781ea
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: The purpose of this study is to evaluate the efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer (NSCLC) who had previously received bevacizumab.Methods: The participants were histopathologically or cytolo
Externí odkaz:
https://doaj.org/article/2c78301b58a14564b18441db71b712d7
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Increasing evidence demonstrates that long noncoding RNAs (lncRNAs) play critical roles in human breast cancer (BC) tumorigenesis. However, the mechanisms by which lncRNA and N6-methyladenosine (m6A) regulate BC tumorigenesis are still uncle
Externí odkaz:
https://doaj.org/article/0a9bf09b364b4ec2a4449b83feccb008
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
N6-methyladenosine (m6A) is the most prevalent type of RNA modification, and we hypothesized that patterns of m6A-related genes may be useful for estimating risk of lung adenocarcinoma (LUAD). An m6A-related gene set variation score (m6A-GSVS) was ge
Externí odkaz:
https://doaj.org/article/e8bb6a070ba3474a8e55656bb99f6ada
Autor:
Mifen Chen, Zhenghang Wang, Zimin Liu, Ting Deng, Xiaodong Wang, Zhiwei Chang, Qi Zhang, Wenlei Yang, Ning Liu, Zhi Ji, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Yi Li, Yujuan Cao, Xuan Jin, Hongxia Lu, Huajun Qu, Yong Tang, Chunlei Xu, Weijia Fang, Hangyu Zhang, Dong Yan, Li Wang, Jiayi Li, Jingdong Zhang, Qiwei Wang, Liying Xue, Fei Yin, Guangjie Han, Zhiqiang Cheng, Qing Liu, Yongdong Jin, Yinjie Zhang, Lanxing Li, Baoshan Cao, Yanhong Yao, Zhiyu Chen, Jianling Zou, Jieer Ying, Qing Wei, Tiantian Tian, Weifeng Zhao, Longmei Li, Tong Zhang, Fanghua Song, Ya-er Ba, Na Li, Hui Gao, Yinghua Ji, Liying Bao, Xiaochen Zhao, Jinping Cai, Zheping Yuan, Lin Shen, Jian Li
Publikováno v:
JCO Precision Oncology.
PURPOSE To investigate the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy versus anti–PD-1/PD-L1 monotherapy in advanced microsatellite instability (MSI)/mismatch repair-deficient (dMMR) gastrointestinal cancers. METHODS We retrospectively rec
Autor:
Mifen, Chen, Zhenghang, Wang, Zimin, Liu, Ning, Liu, Weijia, Fang, Hangyu, Zhang, Xuan, Jin, Jiayi, Li, Weifeng, Zhao, Huajun, Qu, Fanghua, Song, Zhiwei, Chang, Yi, Li, Yong, Tang, Chunlei, Xu, Xiaotian, Zhang, Xicheng, Wang, Zhi, Peng, Jinping, Cai, Jian, Li, Lin, Shen
Publikováno v:
Cancers; Volume 14; Issue 20; Pages: 5158
Background: In microsatellite instability (MSI)/mismatch repair-deficient (dMMR) gastrointestinal cancers, the optimum therapy after the progression of immune checkpoint inhibitors (ICIs) is yet unknown. Here, we compared the efficacy of programmed d
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-9 (2021)
Cell Death Discovery
Cell Death Discovery
Increasing evidence demonstrates that long noncoding RNAs (lncRNAs) play critical roles in human breast cancer (BC) tumorigenesis. However, the mechanisms by which lncRNA and N6-methyladenosine (m6A) regulate BC tumorigenesis are still unclear. In th
Publikováno v:
Frontiers in Oncology; 3/31/2023, Vol. 13, p1-14, 14p
Autor:
Miaomiao Yang1, Huajun Qu1, Aina Liu1, Jiannan Liu1, Ping Sun1 sunping20039@hotmail.com, Hua Li2 693169613@qq.com
Publikováno v:
Journal of Cancer Research & Therapeutics. 2019, Vol. 15 Issue 7, p1561-1566. 6p.
Autor:
Steven Mo, Ai-Na Liu, Jing Hu, Huajun Qu, Hui-Juan Zhang, Congcong Wang, Ping Sun, Fenge Jiang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
N6-methyladenosine (m6A) is the most prevalent type of RNA modification, and we hypothesized that patterns of m6A-related genes may be useful for estimating risk of lung adenocarcinoma (LUAD). An m6A-related gene set variation score (m6A-GSVS) was ge